Pneumococcal disease
Conditions
Interventions
pay it forward group:Participants in this group were informed of the standard cost of the 23-valent pneumococcal polysaccharide vaccine, but previous vaccinees had already made donations to cover part
self-pay group:Participants in this group were informed of the normal cost of the 23-valent pneumococcal polysaccharide vaccine, and after watching a pneumonia vaccine promotional video, participants
Sponsors
Guangxi Medical University
Eligibility
Sex/Gender
All
Age
2 Years to No maximum
Inclusion criteria
Inclusion criteria: (i) Children aged 2-6 years (less than 7 years old) or older adults aged =60 years old; (ii) Meeting medical requirements for vaccination with 23-valent pneumococcal polysaccharide vaccine; (iii) Have resided in the local community for the past three months; (iv) Mentally competent to provide informed consent for vaccination.
Exclusion criteria
Exclusion criteria: (i) Children or older adults with severe chronic or psychiatric illnesses; (ii) Children or older adults with a clinically evaluated risk of allergy to the 23-valent pneumococcal polysaccharide vaccine; (iii) Children or older adults who have received 23-valent pneumococcal polysaccharide vaccine within 5 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 23-valent pneumococcal polysaccharide vaccination rate: 23-valent pneumococcal polysaccharide vaccination rate in each group = (number of participants vaccinated with 23-valent pneumococcal polysaccharide vaccine in each group/total number of persons enrolled in each group)*100%; | — |
Secondary
| Measure | Time frame |
|---|---|
| Cost-effectiveness analysis of 23-valent pneumococcal polysaccharide vaccine;Differences in willingness to vaccinate with 23-valent pneumococcal polysaccharide vaccine; differences in recommending unvaccinated people to receive 23-valent pneumococcal polysaccharide vaccine;Differences in vaccine safety and incidence of adverse reactions;Differences in attitudes towards vaccination against 23-valent pneumococcal polysaccharide vaccine;Differences in perceptions of gratitude;Differences in knowledge of 23-valent pneumococcal polysaccharide vaccination; | — |
Countries
China
Contacts
Public ContactBingyu Liang
Guangxi Medical University
Outcome results
None listed